Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HIV / AIDS specialty page provides HIV/AIDS-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HIV / AIDS NEWS - Page 14

ART Taken Four Days a Week Found to Be as Effective as Daily Regimen
Investigators are finding that a 4-days-a-week regimen of antiretroviral therapy (ART) may be as safe and effective as daily therapy in treating HIV, while keeping costs down and lowering risks of side effects.
The Global Fund Finally Commits Future to Sands: Public Health Watch
Questions regarding a finance executive’s expertise in infectious diseases aside, the move seems straightforward enough—at least on the surface.
High Treatment Uptake is Possible for HCV Patients Coinfected with HIV
A new study examines HCV treatment uptake in HCV patients coinfected with HIV.
Caribbean Region Closer to Eliminating Mother-to-Child HIV Transmission
A new announcement marks the elimination of mother-to-child HIV transmission in 6 Caribbean territories and states
NIH Announces First Trial Assessing Safety of Injectable HIV PrEP in Women
The National Institutes of Health (NIH) have announced plans for a new trial testing the effectiveness of the injectable pre-exposure prophylaxis (PrEP) drug, cabotegravir, in sexually-active women.
World AIDS Day: Addressing the Challenges Ahead in the Fight Against HIV—Special Public Health Watch Report
Although much has changed since the first World AIDS Day in 1988, the effects of the disease on public health remain significant, even as more individuals are “living” with the virus and fewer are dying from it.
HIV Patients with Cancer May Have a New Treatment Option
Individuals with cancer and HIV used to be excluded from clinical trials due to safety concerns, but new positive results open up treatment avenues for this population.
Merck's ISENTRESS Approved by FDA to Treat HIV-1 in Newborns
The FDA has approved Merck’s ISENTRESS to be used in combination with other antiretroviral agents to treat HIV-1 in certain newborns.
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.